Hubei Goto Biopharm Co.,Ltd.

SZSE:300966 Stock Report

Market Cap: CN¥1.8b

Hubei Goto BiopharmLtd Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 300966?
Owner TypeNumber of SharesOwnership Percentage
Public Companies3,117,9292.7%
Institutions6,413,7155.56%
Private Companies6,867,9005.96%
General Public47,393,83741.1%
Individual Insiders51,485,92544.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 24 shareholders own 58.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.7%
Zubin Xi
36,567,000CN¥558.0m0%no data
11.9%
Minglei Li
13,725,300CN¥209.4m0%no data
4.77%
Beijing Joint Innovation Investment Partnership Enterprise (Limited Partnership)
5,501,200CN¥83.9m0%no data
2.7%
Zhejiang Huahai Pharmaceutical Co., Ltd.
3,117,929CN¥47.6m0%no data
1.94%
Anhui Lichang Investment Center (Limited Partnership)
2,235,700CN¥34.1m0%no data
1.4%
Hubei Gaojin Investment Management Co., Ltd.
1,613,185CN¥24.6m0%no data
1.19%
Shenzhen Jiajun Lihao Investment Development Co., Ltd.
1,366,700CN¥20.9m0%no data
1.04%
Jianjun Jiang
1,193,625CN¥18.2m0%no data
1.01%
Yichang Yuehe Equity Investment Fund Management Co., Ltd.
1,164,300CN¥17.8m0%no data
0.6%
Hubei Gaotou Xinlong Investment Management Co., Ltd.
689,800CN¥10.5m0%no data
0.4%
CITIC Securities Company Limited, Asset Management Arm
457,042CN¥7.0m0%0.01%
0.08%
Western Leadbank Fund Management Co., Ltd.
92,700CN¥1.4m0%0.01%
0.063%
Bosera Asset Management Co., Ltd.
72,200CN¥1.1m0%no data
0.023%
Wanjia Asset Management Co., Ltd.
26,700CN¥407.4k0%no data
0.02%
Guotai Asset Management Company Limited
23,500CN¥358.7k0%no data
0.02%
Huatai-PineBridge Fund Management Co., Ltd.
22,500CN¥343.4k0%no data
0.01%
Great Wall Fund Management Co., Ltd
11,600CN¥177.0k0%no data
0.0012%
China Universal Asset Management Company Ltd.
1,386CN¥21.1k0%no data
0.0011%
HFT Investment Management Co. Ltd. (Group)
1,300CN¥19.9k0%no data
0.0005%
Penghua Fund Management Co., Ltd.
572CN¥8.8k0%no data
0.00032%
GF Fund Management Co., Ltd.
372CN¥5.6k0%no data
0.00025%
Harvest Fund Management Co. Ltd.
286CN¥4.4k0%no data
0.00025%
ICBC Credit Suisse Asset Management Co., Ltd.
286CN¥4.4k0%no data
0.00025%
Lion Fund Management Co. Ltd.
286CN¥4.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 13:17
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Goto Biopharm Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution